News from all over the world

AstraZeneca's dynamic duo wants to dominate in cancer drugs    STAT Pancreatic cancer therapy sheds light on the disease's ties to...

AstraZeneca's dynamic duo wants to dominate in cancer drugs - STAT

  1. AstraZeneca's dynamic duo wants to dominate in cancer drugs  STAT
  2. Pancreatic cancer therapy sheds light on the disease's ties to BRCA mutation  CNN
  3. ASCO: AZ, Merck's Lynparza fends off pancreatic cancer, cutting progression risk in half  FiercePharma
  4. New drug therapy slows spread of pancreatic cancer: study  St. Lucia News Online
  5. Lynparza stalls pancreatic cancer in patients with BRCA mutations: study  CNA
  6. View full coverage on Google News


from Top stories - Google News http://bit.ly/2W5VroN

0 coment�rios: